[Pharmacological and clinical profile of Budesonide inhalation suspension (Pulmicort inhalation liquid), an inhaled steroid drug for asthma].
Watanabe
Hideko
H
Hideko.Watanabe@astrazeneca.com
Yano
Seiichi
S
Kageyama
Akihiko
A
D000280:Administration, Inhalation; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000494:pharmacology; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000494:pharmacology; D019819:Budesonide / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000494:pharmacology; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D002986:Clinical Trials as Topic; D064420:Drug-Related Side Effects and Adverse Reactions; D004951:Esterification; D005938:Glucocorticoids / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000494:pharmacology; D006801:Humans; D012137:Respiratory System / Q000378:metabolism
D000893:Anti-Inflammatory Agents; D001993:Bronchodilator Agents; D005938:Glucocorticoids; D019819:Budesonide